US 7582744
Chemically modified oligonucleotides
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 7582744 (Chemically modified oligonucleotides) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/54, A61K47/543